Longevity Health Holdings Inc. Delisted from Nasdaq, Moves to OTC Markets Following Rule Violation
Longevity Health Holdings Inc., a Delaware-based corporation, announced that it received a notice from the Nasdaq Stock Market LLC on September 10, 2025, regarding a failure to meet Nasdaq Listing Rule 5550(b)(2). Consequently, the Nasdaq Panel has decided to delist the company's securities from the Nasdaq Capital Market, effective at the start of trading on September 12, 2025. Following this decision, the company's common stock and warrants will be traded on the over-the-counter markets operated by OTC Markets Group, Inc. Despite this transition, Longevity Health Holdings intends to maintain its operations and continue filing reports as required by the Securities Exchange Act of 1934. The company also remains committed to pursuing a merger with True Health Inc. and relisting the merged entity's securities on Nasdaq.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longevity Health Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-114421), on September 12, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。